Usa Stocks Insider
  • Business
  • World
  • Investing
  • Stocks

Usa Stocks Insider

  • Business
  • World
  • Investing
  • Stocks
World

China suggests Covid-19 originated in US in response to Trump allegation

by admin May 1, 2025
May 1, 2025
China suggests Covid-19 originated in US in response to Trump allegation

China restated its case that Covid-19 may have originated in the United States in a white paper on its pandemic response released on Wednesday, after President Donald Trump’s administration blamed a lab leak in China.

The White House launched a Covid-19 website on April 18 in which it said the coronavirus came from a lab leak in China while criticizing former President Joe Biden, former top US health official Anthony Fauci and the World Health Organization (WHO).

In the white paper, released by the official Xinhua news agency, China accused the US of politicizing the matter of the origins of Covid-19. It cited a Missouri lawsuit which resulted in a $24 billion ruling against China for hoarding protective medical equipment and covering up the outbreak.

China shared relevant information with the WHO and the international community in a timely manner, the white paper said, emphasizing that a joint study by the WHO and China had concluded that a lab leak was “extremely unlikely.”

The US should not continue to “pretend to be deaf and dumb,” but should respond to the legitimate concerns of the international community, the white paper said.

“Substantial evidence suggested the Covid-19 might have emerged in the United States earlier than its officially-claimed timeline, and earlier than the outbreak in China,” it said.

The CIA said in January the pandemic was more likely to have emerged from a lab in China than from nature, after the agency had for years said it could not reach a conclusion on the matter. It said it had “low confidence” in its new assessment and noted that both lab origin and natural origin remain plausible.

An official at China’s National Health Commission said the next step in origin-tracing work should focus on the US, according to Xinhua, which cited a statement about the white paper.

This post appeared first on cnn.com

0
FacebookTwitterGoogle +Pinterest
previous post
Ready To Level Up Your Options Trading?
next post
King Charles reflects on ‘darkest moments’ of cancer diagnosis

You may also like

Trump considers attending Ukraine-Russia talks in Turkey

May 13, 2025

Ellen Miles is planting seeds of hope through...

May 9, 2025

Family and friends shattered and scarred by tourist...

April 26, 2025

Crowds gather for Pope Francis’ funeral Mass at...

April 26, 2025

Japan and China accuse each other of violating...

May 5, 2025

Israeli military says it has launched first stages...

May 17, 2025

Relatives of El Chapo enter US as part...

May 14, 2025

Ukraine says it has uncovered Hungarian spy network...

May 10, 2025

Israel targets Hamas leader Mohammed Sinwar in hospital...

May 14, 2025

‘Be bold and do it anyway’: Mo Abudu...

May 2, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Legendary Brazilian photographer Sebastião Salgado dead at 81

      May 24, 2025
    • At least 12 injured in hot air balloon crash in Mexico

      May 24, 2025
    • Several people sustain ‘life-threatening’ injuries in knife attack at Hamburg’s Central Station, police say

      May 24, 2025
    • ‘What was that bang?’ Footage captures sound of Titan sub’s implosion

      May 24, 2025
    • We’re ‘poker chips’: International Harvard students describe fear after Trump administration moves to revoke their enrollment

      May 24, 2025

    Categories

    • Business (70)
    • Investing (245)
    • Stocks (113)
    • World (290)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: usastocksinsider.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 usastocksinsider.com | All Rights Reserved